Spots Global Cancer Trial Database for metastatic renal cancer
Every month we try and update this database with for metastatic renal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Everolimus Modulation of Anti-tumor T CD4 Immune Responses | NCT02837757 | Metastatic Rena... | Biological samp... | 18 Years - | Centre Hospitalier Universitaire de Besancon | |
| Modified White Blood Cells That Secrete IL-2 and Express a Protein That Targets the ESO-1tumor Protein for Metastatic Cancer | NCT01457131 | Metastatic Canc... Metastatic Mela... Metastatic Rena... | Fludarabine Cyclophosphamid... IL-12 & Ant... | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Safety Study of TroVax Alone vs. TroVax Plus Interferon Alpha in Patients With Renal Cancer | NCT00445523 | Carcinoma, Rena... | TroVax® (Immuno... Interferon-alph... | 18 Years - | The Methodist Hospital Research Institute | |
| PRednisone Plus EVerolimus in Patients With Metastatic Renal Cell Cancer After Failure of VEGFR -TKI | NCT02479490 | Metastatic Rena... | Prednisone + Ev... | 18 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma | NCT03427476 | Renal Cell Carc... | CTT1057 | 18 Years - | Cancer Targeted Technology | |
| PRednisone Plus EVerolimus in Patients With Metastatic Renal Cell Cancer After Failure of VEGFR -TKI | NCT02479490 | Metastatic Rena... | Prednisone + Ev... | 18 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| Ketogenic Diet for Patients Receiving First Line Treatment for Metastatic Renal Cell Carcinoma | NCT04316520 | Metastatic Rena... | Ketogenic diet | 18 Years - | University Hospital, Angers | |
| Safety and Compliance of Renal Cancer Patients Treated by Non-IV Drugs | NCT03630692 | Metastatic Rena... Stage III Renal... | observance of o... | 18 Years - | Institut Cancerologie de l'Ouest | |
| Measuring Oncological Value of Exercise and Statin | NCT05796973 | Prostate Cancer Breast Cancer Kidney Cancer Ovarian Cancer Metastatic Brea... Metastatic Kidn... Metastatic Rena... Metastatic Rena... Metastatic Pros... Metastatic Pros... Metastatic Ovar... Metastatic Ovar... | Guided physical... Atorvastatin Independent exe... | 18 Years - 99 Years | Tampere University Hospital | |
| Everolimus Modulation of Anti-tumor T CD4 Immune Responses | NCT02837757 | Metastatic Rena... | Biological samp... | 18 Years - | Centre Hospitalier Universitaire de Besancon | |
| Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases | NCT02859415 | Esophageal Neop... Lung Neoplasms Mesothelioma Thymus Neoplasm... Neoplasms, Germ... | Mithramycin | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Phase II Study of Aldesleukin (IL-2) Following the Administration of Zanolimumab (Anti-CD4mAb) in Metastatic Melanoma and Metastatic Renal Cancer | NCT01160445 | Metastatic Mela... Metastatic Rena... | Zanolimumab Aldesleukin | 18 Years - | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
